ioxilan has been researched along with Renal Insufficiency, Chronic in 1 studies
Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)
Excerpt | Relevance | Reference |
---|---|---|
"Sodium bicarbonate has been suggested as a possible strategy for prevention of contrast medium-induced nephropathy, a common cause of renal failure associated with prolonged hospitalization, increased health care costs, and substantial morbidity and mortality." | 2.73 | Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. ( Aharonian, VJ; Brar, SS; Burchette, RJ; Desai, N; Jorgensen, MB; Kotlewski, A; Ree, M; Shah, AI; Shen, AY, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brar, SS | 1 |
Shen, AY | 1 |
Jorgensen, MB | 1 |
Kotlewski, A | 1 |
Aharonian, VJ | 1 |
Desai, N | 1 |
Ree, M | 1 |
Shah, AI | 1 |
Burchette, RJ | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Randomized Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate[NCT00312117] | Phase 3 | 300 participants | Interventional | 2006-01-31 | Completed | ||
Sodium Bicarbonate to Treat Severe Acidosis in the Critically Ill : A Multiple Center Randomized Clinical Trial (BICAR-ICU)[NCT02476253] | Phase 3 | 400 participants (Anticipated) | Interventional | 2015-05-05 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for ioxilan and Renal Insufficiency, Chronic